|9 Months Ended|
Sep. 30, 2014
|Goodwill and Intangible Assets Disclosure [Abstract]|
Intangible assets of the Company consisted of the following:
Other than the website as set forth in the table above, intangible assets are comprised of patents with estimated useful lives between approximately 1 to 15 years. The website was determined to have an estimated useful life of 3 years. Once placed in service, the Company will amortize the costs of intangible assets over their estimated useful lives on a straight-line basis. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. Amortization of patents is included in operating expenses as reflected in the accompanying consolidated statements of operations. The Company assesses fair market value for any impairment to the carrying values. As of September 30, 2014 and December 31, 2013 management concluded that there was no impairment to the acquired assets.
Patent and website amortization expense for the nine months ended September 30, 2014 and 2013 was $2,872,638 and $860,657, respectively. Future amortization of intangible assets, net is as follows:
The Company made the following patent purchases:
- On April 16, 2013, the Company through its subsidiary, Relay IP, Inc. acquired a US patent for $350,000.
- On April 22, 2013, the Company acquired 10 US patents, 27 foreign patents and 1 patent pending from CyberFone Systems valued at $1,135,512 (see note 3).
- In September 2013, in two transactions, the Company acquired 14 US patents for a total purchase price of $1,100,000.
- On November 13, 2013, the Company acquired four patents for 150,000 shares of the Companys common stock, which the Company valued at $718,500 based on the fair market value of the stock issued.
- On December 16, 2013, the Company acquired 15 US and 2 foreign patents from Delphi Technologies, Inc. for $1,700,000 pursuant to a Patent Purchase Agreement entered into on October 31, 2013 and Amended on December 16, 2013.
In connection with a settlement and license agreement dated June 4, 2013, the Company agreed to settle and release a certain defendant for past and future use of the Companys patents. The defendant agreed to assign and transfer 3 US patents and rights valued at $1,000,000.
In connection with a settlement and license agreement dated December 22, 2013, the Company agreed to settle and release another defendant for past and future use of the Companys patents, whereby the defendant agreed to assign and transfer 2 US patents and rights to the Company. The Company valued the two patents at an aggregate of $700,000.
As of September 30, 2014, the Companys patent portfolios consist of 203 U.S. and foreign patents, twenty-two open patent applications and contract rights to 6 patents. During the second quarter of 2013, the Company began to generate revenue from its patent portfolio. In the aggregate, the earliest date for expiration of a patent in the Companys patent portfolio is past (the patent is expired, but patent rules allow for six year look-back for royalties), the median expiration date for patents in the Companys portfolio is June 17, 2017, and the latest expiration date for a patent in any of the Companys patent portfolios is March 9, 2029. A summary of the Companys patent portfolios is as follows:
The entire disclosure for all or part of the information related to intangible assets.
Reference 1: http://www.xbrl.org/2003/role/presentationRef